Krystal Biotech (KRYS) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 07/18/24
Earnings Estimates Moving Higher for Krystal Biotech (KRYS): Time to Buy?Zacks Investment Research • 05/23/24
Krystal Biotech to Present at the American Thoracic Society 2024 International ConferenceGlobeNewsWire • 05/15/24
Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss EstimatesZacks Investment Research • 05/06/24
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business UpdatesGlobeNewsWire • 05/06/24
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingGlobeNewsWire • 05/02/24
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024GlobeNewsWire • 04/26/24
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a TurnaroundZacks Investment Research • 04/23/24
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the LungGlobeNewsWire • 04/22/24
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual MeetingGlobeNewsWire • 04/04/24
Newer Treatments In Alpha-1 Antitrypsin Deficiency: $2.5 Billion/Year Market Size By 2032Seeking Alpha • 03/14/24
Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 03/14/24
Can Krystal Biotech, Inc. (KRYS) Run Higher on Rising Earnings Estimates?Zacks Investment Research • 03/08/24
Krystal Biotech, Inc. (KRYS) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 03/08/24
Here's Why Momentum in Krystal Biotech, Inc. (KRYS) Should Keep goingZacks Investment Research • 02/27/24